Evofem Biosciences to Report Third Quarter 2018 Results on November 7, 2018

-- Conference Call Scheduled for 11:00 a.m. EST --

News provided by

Oct 24, 2018, 08:30 ET

SAN DIEGO, Oct. 24, 2018 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem"), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, will hold a conference call to discuss financial results and business highlights for the quarter ended September 30, 2018, as follows:

Date	Wednesday November 7, 2018
Time	11:00 a.m. EST
Dial-in numbers	(866) 503-5561 (U.S. toll-free) or (253) 336-2965
Passcode	9158219
Webcast (live and archived)	www.evofem.com under "Investors" or click here

The teleconference replay will be available approximately two hours after completion through Monday, November 12, 2018, at (855) 859-2056 (U.S.) or (404) 537-3406 (International). The replay access code is 9158219. The archived webcast will be available via the aforementioned URLs.

About Evofem Biosciences
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. Evofem is leveraging its proprietary Multipurpose Vaginal pH Regulator (MVP-R) to develop product candidates for multiple indications, including contraception, the prevention of urogenital transmission of chlamydia and gonorrhea in women, and recurrent bacterial vaginosis. For more information regarding Evofem, please visit www.evofem.com.

Investor Contact
Amy Raskopf
Evofem Biosciences, Inc.
[email protected]
O: (858) 550-1900 x167
M: (917) 673-5775

Media Contact
Sophia Ononye
RXMD
[email protected]
O: (646) 599-8630
M: (917) 557-1909

SOURCE Evofem Biosciences, Inc.